2009
DOI: 10.1016/s1873-9946(09)60130-6
|View full text |Cite
|
Sign up to set email alerts
|

P103 - Mesenchymal stem cells administered via novel selective mesenteric artery cannulation for the treatment of severe refractory Crohn's disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0

Year Published

2010
2010
2016
2016

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(8 citation statements)
references
References 0 publications
0
8
0
Order By: Relevance
“…Although it has been suggested that MSCs home to sites of inflammation, it is unknown how many cells will eventually reach the intestine in patients with Crohn's disease. In a case report, Dinesen et al 20 showed that administration of MSCs via selective mesenteric artery cannulation was safe and feasible. This approach may possibly increase the number of cells reaching the affected organ.…”
Section: Discussionmentioning
confidence: 99%
“…Although it has been suggested that MSCs home to sites of inflammation, it is unknown how many cells will eventually reach the intestine in patients with Crohn's disease. In a case report, Dinesen et al 20 showed that administration of MSCs via selective mesenteric artery cannulation was safe and feasible. This approach may possibly increase the number of cells reaching the affected organ.…”
Section: Discussionmentioning
confidence: 99%
“…This group injected haploidentical MSCs after catheterization of the mesenteric artery via the femoral route in a 35-years-old patient with severe refractory fistulizing CD failing all conventional therapies, biological therapies, and surgical ileostomy. The treatment led to a reduction in CDAI but only slight changes in MRI-imaging of fistulous tracts were detected [114].…”
Section: Unanswered Questions and Future Perspectivesmentioning
confidence: 96%
“…However, it is known that many MSCs are stopped in the lungs, and the proportion of MSCs reaching the inflamed intestine has not been evaluated. Infusion of MSCs via the mesenteric artery may increase the amount of MSCs reaching the inflamed organ and has been successfully performed in one patient without any complication . However, this route of administration is clearly more invasive, and its interest appears minimal as intravenous infusion seems efficient.…”
Section: Msc Therapy In Ibdmentioning
confidence: 99%